Eye drops replace tears that already evaporated. But they can’t stop the evaporation. That’s the job of the oil layer. A thin coat of lipid that sits on top of your tear film and seals moisture in. That oil comes from tiny glands in your eyelids called meibomian glands. When those glands are inflamed, clogged, or starving for raw materials (from hormonal shifts, screen exposure, aging, or all three) the oil layer collapses. Tears hit the air and vanish in seconds. You put in more drops. They vanish too. The drop isn’t failing. The gland underneath is. Until you feed the gland, the drop is a bandaid on a leak.*

Ophthalmologists are trained in procedures and prescriptions. IPL sessions bill at $400. Restasis refills bill monthly. Meibomian gland expression requires a follow-up visit. A capsule taken at home with breakfast generates no procedure code. No referral fee. No recurring appointment. It’s not a conspiracy. It’s how the system is built. There’s revenue in treating the symptom every month. There’s no revenue in resolving the underlying deficiency. That’s why 9 out of 10 dry eye patients are never told that their oil glands can be fed from the inside.*

PreserVision and Ocuvite were designed around a 2001 study called AREDS2. That study was built for age-related macular degeneration in seniors. Not for dry eyes. Not for tear film collapse. Not for meibomian gland dysfunction. Those formulas use 10mg Lutein (half the clinical dose), zero Meso-Zeaxanthin (the one carotenoid that protects the dead center of your macula), zero Astaxanthin (the only carotenoid proven to cross the blood-retinal barrier and reduce ocular inflammation), and an 80mg zinc megadose that causes nausea in 25% of users. Worst of all, they’re dry pressed tablets with no lipid carrier. Lutein and Zeaxanthin are fat-soluble. Without fat, they pass through your gut unabsorbed. You’re swallowing the ingredients your eyes need and flushing them straight through. VisioVance uses 20mg Lutein, includes all three macular carotenoids, adds Astaxanthin and Saffron for inflammation and photoreceptor support, and delivers everything inside a capsule with a built-in Omega-3 carrier so the compounds actually reach the tissue.*

Week 1-2: Most people feel nothing. This is normal. The Omega-3 is beginning to rebuild lipid stores in the meibomian glands. The Astaxanthin is accumulating in the eye tissue. You won’t feel it yet. If something claims to work overnight, it’s not doing what this does.

Week 2-4: First signs. Less afternoon grit. Fewer times reaching for drops. Morning eyes open easier. The oil layer is stabilizing. The inflammation is quieting.

Month 2-3: Noticeable shift. Vision feels clearer and more stable. Contact lens wear becomes comfortable again for many users. Night driving halos begin shrinking as macular pigment density builds.

Month 4-6: Peak macular pigment density. The protective carotenoid layer across your retina is at its thickest. This is the long-term shield. The compound that keeps building the longer you take it.

If you stop: the benefits fade within 1-2 weeks. This is not a cure. It’s daily nutritional support for tissue that is under constant demand. The glands need feeding the same way your bones need calcium. Stop feeding them and the depletion returns.*